Financial comparisons Perspective Therapeutics, Inc.

Stocks

Market Closed - NYSE 23:00:00 17/09/2026 +03			5-day change	1st Jan Change
2.880 ^USD	+6.67%		-3.68%	+4.73%

08-19	BMO Capital Initiates Perspective Therapeutics at Outperform	MT
08-14	BofA Securities Adjusts Perspective Therapeutics Price Target to $5 From $6	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Revenues (Y-1)	Net Margin (Y-1)	EBIT Margin (Y-1)	ROE (Y-1)	ROA (Y-1)	Leverage (Y-1)
PERSPECTIVE THERAPEUTICS, INC.	884K	-11,665.27%	-12,846.61%	-41.44%	-	1.3x
LONZA GROUP AG	8.24B	14.53%	21.7%	10.28%	4.9%	1.58x
IQVIA HOLDINGS INC.	16.31B	8.34%	13.38%	32.9%	4.79%	3.63x
BEONE MEDICINES AG	5.34B	5.37%	8.37%	29.84%	16.27%	-5.99x
CELLTRION, INC.	2.88B	24.74%	28.07%	5.94%	4.75%	1.77x
MEDPACE HOLDINGS, INC.	2.53B	17.83%	20.93%	70.23%	22.13%	-0.89x
ASCENDIS PHARMA A/S	846M	-31.67%	-18.92%	-	-	1.57x
EUROFINS SCIENTIFIC SE	8.57B	6.51%	14.79%	9.61%	4.34%	2.22x
ICON PUBLIC LIMITED COMPANY	8.25B	2.78%	16.66%	10.62%	6.02%	1.8x
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	4.02B	-3.59%	19.77%	15.46%	6.99%	1.98x
TEMPUS AI, INC.	1.27B	-19.27%	-3.71%	-38.64%	-6.61%	-65.61x
BIO-TECHNE CORPORATION	1.22B	14.97%	31.77%	15.06%	11.79%	-0.15x
PHARMARON BEIJING CO., LTD.	2.02B	11.8%	13.68%	11.6%	6.52%	1.83x
ABIVAX	5.4M	-7,306.52%	-5,350%	-135.58%	-	2.1x
KYMERA THERAPEUTICS, INC.	39.21M	-794.04%	-891.07%	-25.78%	-22.89%	4.75x
PROTAGONIST THERAPEUTICS, INC.	46.02M	-282.83%	-343.63%	-20.18%	-18.42%	0.82x
GENSCRIPT BIOTECH CORPORATION	960M	-55.53%	26.46%	-12.87%	-10.52%	-0.45x
QIAGEN N.V.	2.09B	20.33%	29.46%	17.5%	10.73%	0.74x
Average	3.59B	-1,112.86%	-1,067.16%	-2.67%	2.72%	-2.61x
Weighted average by Cap.	5.77B	-248.52%	-189.13%	10.5%	5.41%	-1.86x